Patent Royalty Agreement
INTRODUCTION The royalty agreement of patent means that a person having the patented products is ready to delegate his exclusive rights to some extent in the form of license to a person who shall be known as a licensee who…
Intellectual Property (IP) Licensing Laws In Thailand
The word Intellectual Property (IP) signifies the creations of the human mind. For instance, literary and artistic works; inventions; designs; symbols, names and images used in commercial ventures. Even though, Intellectual Property is an extremely powerful tool for economic development…
Export Of Patented Product For Research Or Experimental Purposes– A Part Of Bolar Exemption
The High Court of Delhi had finally adjudged, the case of Bayer Corporation v. Union of India & Ors and Bayer Intellectual Property gmbh & Anr, v. Alembic Pharmaceutical Limited by the order dated 22.04.2019, on the scope of section107(A)…
Patent Trolling
Introduction A patent is an exclusive right that is granted to an inventor for a specified number of years to make, use, and sell an invention. Once the right s provided, no other person can use the invention without proper…
Patent Commercialisation Via Licensing
Intellectual Property refers to creations of the mind such as inventions, expressions in the form of literary and artistic works, symbols, names and images, etc used in commerce. It can further be divided into Industrial Property or Copyright[1]. Patent as…
Inside Secure states, France Brevets licenses NFC Patents to HTC
Access to robust data and effective analytics are the must for today's business world. But sometimes it can be difficult to acquire good data. That's where near-field communication (hereinafter referred as “NFC”) technology comes in. NFC is a short-range high-frequency…
Smile, you are on camera!
Every celebrity would agree when we say that stardom comes at a price. Their right to privacy is always threatened with the constant paparazzi encroaching upon their personal lives. Unauthorized photography often results in tabloid and defamatory reports in the…
Natco Files India’s First Compulsory Licensing Application
Natco Pharma has filed India’s first Compulsory Licensing (CL) Application (in accordance with Section 84(1) of the Indian Patents Act) against one of the Bayer’s patented drug Sorafenib, marketed by Bayer as Nexavar for treating Kidney and Liver Cancer. Patent…